A Form 4 filed with the SEC on September 3, 2026 discloses that K. Charles Janac, President and CEO of Arteris, Inc. (NASDAQ:AIP), disposed of 100,000 shares of common stock on September 1, 2026 through a pre-established 10b5-1 trading plan.

Key Highlights

  • Sale transaction: 100,000 shares of Arteris common stock were disposed of on September 1, 2026 at a weighted average price of $20.7497 per share.
  • Price range: The shares were sold in multiple transactions at prices ranging from $20.465 to $21.410, inclusive.
  • 10b5-1 plan: The sale was made pursuant to a 10b5-1 trading plan adopted by K. Charles Janac, as manager of Bayview Legacy, LLC, on December 12, 2025.
  • Post-transaction indirect ownership: Following the transaction, 8,229,071 shares are beneficially owned indirectly through Bayview Legacy, LLC.
  • Additional holdings: The reporting person also holds 175,148 shares directly and 56,252 shares indirectly through the Charles and Lydia Janac Trust.
  • Roles: The reporting person is listed as Director, 10% Owner, and President and CEO of Arteris, Inc.

Janac's Share Sale via Bayview Legacy, LLC at Arteris, Inc.

According to the filing, K. Charles Janac, serving as President and CEO as well as a Director and 10% Owner of Arteris, Inc., disposed of 100,000 shares of common stock on September 1, 2026. The transaction was coded "S" (sale) and carried out indirectly through Bayview Legacy, LLC, of which Janac is the manager. The filing states he "is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC."

The filing discloses that the weighted average sale price was $20.7497 per share, with individual transactions occurring at prices ranging from $20.465 to $21.410 inclusive. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request, according to the filing. The sale was conducted under a 10b5-1 trading plan that the filing states was adopted by Janac, as manager of Bayview Legacy, LLC, on December 12, 2025.

Following the reported transaction, the filing indicates that Bayview Legacy, LLC holds 8,229,071 shares of Arteris common stock beneficially owned indirectly by Janac. Separately, the filing reports 175,148 shares held directly by the reporting person and 56,252 shares held indirectly through the Charles and Lydia Janac Trust, for which Janac serves as trustee. The Form 4 was signed by Paul Alpern as Attorney-in-Fact for K. Charles Janac and filed on September 3, 2026.

What Was Disclosed

Arteris, Inc. President and CEO K. Charles Janac filed a Form 4 reporting the sale of 100,000 shares of common stock on September 1, 2026, executed indirectly through Bayview Legacy, LLC under a pre-established 10b5-1 plan adopted December 12, 2025.